These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2307090)

  • 21. A study of serum free C-peptide responses to oral glucose load in diabetic patients: with special reference to types of diabetes and methods of treatment.
    Hsieh SD; Akanuma Y; Takaku F
    Tohoku J Exp Med; 1984 Mar; 142(3):249-60. PubMed ID: 6374968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous insulin infusion system to determine insulin regimen in diabetics.
    Ito M; Sato T; Saito T; Kokubun M; Inoue M; Saito K; Yoshinaga K
    Tohoku J Exp Med; 1988 Jan; 154(1):29-36. PubMed ID: 3284000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.
    Flint A; Kapitza C; Hindsberger C; Zdravkovic M
    Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absorption kinetics and action profiles after sequential subcutaneous administration of human soluble and lente insulin through one needle.
    Bilo HJ; Heine RJ; Sikkenk AC; van der Meer J; van der Veen EA
    Diabetes Care; 1987; 10(4):466-9. PubMed ID: 3304896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
    Groop L; Wåhlin-Boll E; Groop PH; Tötterman KJ; Melander A; Tolppanen EM; Fyhrqvist F
    Eur J Clin Pharmacol; 1985; 28(6):697-704. PubMed ID: 3933984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test.
    Holst JJ; Buse JB; Rodbard HW; Linjawi S; Woo VC; Boesgaard TW; Kvist K; Gough SC
    J Diabetes Sci Technol; 2015 Oct; 10(2):389-97. PubMed ID: 26443290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circadian profiles of blood glucose and plasma free insulin during treatment with semisynthetic and biosynthetic human insulin, and comparison with conventional monocomponent preparations.
    Castillo M; Nemery A; Verdin E; Lefebvre PJ; Luyckx AS
    Eur J Clin Pharmacol; 1983; 25(6):767-71. PubMed ID: 6363099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of diurnal serum insulin levels during short term treatments with sulfonylurea and with insulin in non-insulin dependent diabetes.
    Fukumoto Y; Ichihara K; Nonaka K; Tarui S
    Horm Metab Res; 1982 Jan; 14(1):1-4. PubMed ID: 6800910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.
    Bogardus C; Lillioja S; Howard BV; Reaven G; Mott D
    J Clin Invest; 1984 Oct; 74(4):1238-46. PubMed ID: 6384267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Glycemic Control on Chylomicron Metabolism and Correlation between Postprandial Metabolism of Plasma Glucose and Chylomicron in Patients with Type 2 Diabetes Treated with Basal-bolus Insulin Therapy with or without Vildagliptin.
    Okajima F; Emoto N; Kato K; Sugihara H
    J Atheroscler Thromb; 2017 Feb; 24(2):157-168. PubMed ID: 27397060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood glucose profiles in insulin-dependent Zambian diabetics.
    Mulaisho C
    Med J Zambia; 1979; 13(5):85-9. PubMed ID: 122431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes: The quest for basal normoglycaemia.
    Holman RR; Turner RC
    Lancet; 1977 Feb; 1(8009):469-74. PubMed ID: 65573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.
    Saisho Y; Kou K; Tanaka K; Abe T; Kurosawa H; Shimada A; Meguro S; Kawai T; Itoh H
    Endocr J; 2011; 58(4):315-22. PubMed ID: 21415555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes.
    Herrera KM; Rosenn BM; Foroutan J; Bimson BE; Al Ibraheemi Z; Moshier EL; Brustman LE
    Am J Obstet Gynecol; 2015 Sep; 213(3):426.e1-7. PubMed ID: 26070699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.
    Sonnenberg GE; Garg DC; Weidler DJ; Dixon RM; Jaber LA; Bowen AJ; DeChemey GS; Mullican WS; Stonesifer LD
    Ann Pharmacother; 1997 Jun; 31(6):671-6. PubMed ID: 9184703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed onset of action of soluble insulin after premixing with U100 lente insulin.
    Heine RJ; Sikkenk AC; Eizenga WH; van der Veen EA
    Diabetes Res Clin Pract; 1986; 2(6):353-8. PubMed ID: 3545725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Associations of insulin resistance and pancreatic beta-cell function with plasma glucose level in type 2 diabetes].
    Nian X; Sun G; Dou C; Hou H; Fan X; Yu H; Ma L; He B
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):732-5. PubMed ID: 12126540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin.
    Olsson PO; Hans A; Henning VS
    Diabetes Care; 1987; 10(4):473-7. PubMed ID: 3304898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.